The WHO is leading a global call for the elimination of cervical cancer by the year 2030. Although the call in itself is ambitious, the adopted strategy is realistic. The WHO is optimistic that cervical cancer will be eliminated as a disease of public health concern if 90% of girls receive the HPV vaccine by 15 years of age, 70% of women are screened by HPV testing at 35 and 45 years, and 90% of identified cases are treated. The success of the global call will significantly depend on the capacity to operationalize, finance, and implement the strategy in low- and middle-income countries (LMIC), where more than 80% of the disease burden resides. This capacity varies among and within countries. A SWOT (strength, weakness, opportunity, and threat) analysis of the WHO global strategy for elimination of cervical cancer, conducted through the lens of experience in planning and advocating for a comprehensive cervical cancer prevention program in Kebbi State, Nigeria, highlights the delicate balance between evidence of efficacy and science of implementation that program managers in LMIC have to consider while rolling out or scaling up cervical cancer prevention programs.
|Number of pages||6|
|Journal||International Journal of Gynecology and Obstetrics|
|Publication status||Published - 25 Nov 2020|
Bibliographical noteFunding Information:
The activities that informed our experience on the planning and advocating for cervical cancer prevention in Kebbi State were funded by a Global Scholar Grant of the American Cancer Society. We are grateful to Dr. Zainab Atiku-Bagudu, Founder of the Medicaid Cancer Foundation (MCF), for allowing us to piggyback on her foundation’s cancer intervention programs in Kebbi State. Ophira Ginsburg read the initial draft and offered useful advice to translate our experience into a review.
© 2020 International Federation of Gynecology and Obstetrics